AURAAura Biosciences, Inc.

Healthcare
$6.50+13% 1Y

The financials

Aura Biosciences, Inc. by the numbers

The next results filing is expected around Nov 12, 2026, the same week as a year ago.

Aura Biosciences, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Operating income−$48M−$29Mn/a
Net income−$46M−$27Mn/a
Diluted EPS−$0.48−$0.47n/a

Biotechnology

Ranks #131 of 196 by RyuScore

Compare peers
SLDB-0.51%
Solid Biosciences Inc.
OABI+1.9%
OmniAb, Inc.
GUTS-7.4%
FRACTYL HEALTH, INC.
FDMT+0.79%
4D Molecular Therapeutics, Inc.
IMMX-1.9%
Immix Biopharma, Inc.
OLMA-1.5%
Olema Pharmaceuticals, Inc.